IL177227A - Zulfide preparations for the administration of hypnotic factor through the oral mucosa to treat insomnia - Google Patents

Zulfide preparations for the administration of hypnotic factor through the oral mucosa to treat insomnia

Info

Publication number
IL177227A
IL177227A IL177227A IL17722706A IL177227A IL 177227 A IL177227 A IL 177227A IL 177227 A IL177227 A IL 177227A IL 17722706 A IL17722706 A IL 17722706A IL 177227 A IL177227 A IL 177227A
Authority
IL
Israel
Prior art keywords
zolpidem
delivering
compositions
oral mucosa
treating insomnia
Prior art date
Application number
IL177227A
Other languages
English (en)
Hebrew (he)
Other versions
IL177227A0 (en
Original Assignee
Transcept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcept Pharmaceuticals Inc filed Critical Transcept Pharmaceuticals Inc
Publication of IL177227A0 publication Critical patent/IL177227A0/en
Publication of IL177227A publication Critical patent/IL177227A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL177227A 2004-02-17 2006-08-02 Zulfide preparations for the administration of hypnotic factor through the oral mucosa to treat insomnia IL177227A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78311804A 2004-02-17 2004-02-17
US59862904P 2004-08-03 2004-08-03
PCT/US2005/005021 WO2005079761A1 (fr) 2004-02-17 2005-02-16 Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation

Publications (2)

Publication Number Publication Date
IL177227A0 IL177227A0 (en) 2006-12-10
IL177227A true IL177227A (en) 2013-05-30

Family

ID=34890604

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177227A IL177227A (en) 2004-02-17 2006-08-02 Zulfide preparations for the administration of hypnotic factor through the oral mucosa to treat insomnia

Country Status (7)

Country Link
AU (1) AU2005215782B2 (fr)
BR (1) BRPI0507733A (fr)
CA (1) CA2556450C (fr)
IL (1) IL177227A (fr)
MX (1) MXPA06009296A (fr)
NZ (1) NZ548856A (fr)
WO (1) WO2005079761A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
JP2008542299A (ja) * 2005-05-25 2008-11-27 トランセプト・ファーマシューティカルズ・インコーポレイテッド 真夜中不眠症の治療のための固体組成物およびその治療方法
EP2455076A1 (fr) * 2007-04-09 2012-05-23 Sepracor Inc. Compositions comprenant la desvenlafaxine pour leur utilisation dans le traitement des troubles respiratoires liés au sommeil
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
CN103919780B (zh) * 2012-12-26 2016-12-28 上海中西制药有限公司 镇静安眠制剂、其复方制剂、制备方法及药物组合物
MA53050B1 (fr) * 2018-10-08 2023-03-31 Troikaa Pharmaceuticals Ltd Solutions oromuqueuses de zolpidem ou sels pharmaceutiquement acceptables de celles-ci

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6624162B2 (en) * 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators

Also Published As

Publication number Publication date
CA2556450A1 (fr) 2005-09-01
AU2005215782B2 (en) 2011-04-21
CA2556450C (fr) 2013-08-06
BRPI0507733A (pt) 2007-07-10
MXPA06009296A (es) 2007-01-26
IL177227A0 (en) 2006-12-10
WO2005079761A1 (fr) 2005-09-01
AU2005215782A1 (en) 2005-09-01
NZ548856A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
EP1715853A4 (fr) Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation
IL227117A (en) A pharmaceutical preparation that contains insulin in a form that allows oral administration
IL173742A0 (en) Compositions for delivering 5-ht agonists across the oral mucosa
IL181304A (en) Use of dihydroprididone for the preparation of a drug for the treatment of spinal cord dysplasia
EP1968554A4 (fr) Formulations de médicaments bioadhésifs pour administration par voie transmucosale orale
ZA200505274B (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
EP1750677A4 (fr) Systeme d'administration orale de compose therapeutique
PL1973422T3 (pl) Kompozycje zapewniające wrażenie ogrzewania do dostarczania doustnego i skórnego
EP1806148A4 (fr) Préparation thérapeutique pour inhalation
GB0427856D0 (en) Maniflod for use in medicament dispenser
EP1761250A4 (fr) Systeme d'administration par voie orale
IL216104A0 (en) Coated drug delivery formulations
PL1807156T3 (pl) Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności
IL213897A0 (en) Ultrasound contrast agent dosage formulation
IL177227A (en) Zulfide preparations for the administration of hypnotic factor through the oral mucosa to treat insomnia
IL182999A0 (en) Transmucosal oral delivery device
GB0304636D0 (en) Pharmaceutical composition for nasal delivery
IL180316A0 (en) Quinolone-containing medicinal composition
GB0228305D0 (en) Therapeutic composition for respiratory delivery
ZA200607996B (en) Lozenge for delivery of dextromethorphan
ZA200606411B (en) Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
AU2003296961A8 (en) Targeted invitation delivery
HK1172830A1 (en) Ultrasound contrast agent dosage formulation
ZA200603126B (en) Pharmaceutical compositions for therapeutic use
GB0420250D0 (en) Method for oral drug delivery

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees